Participated · Equity · Dec 2025

Ren-Gas is a Finnish power-to-gas company focused on converting renewable electricity into green hydrogen and e-methane for heavy-duty trucks and maritime vessels. Its core offering is a nationwide network of e-methane production plants built in partnership with local energy companies. The flagship facility in Tampere has reached construction-ready status, and the broader pipeline exceeds 700 MW of planned electrolysis capacity—enough fuel output for roughly 7,000 heavy trucks per year. In December 2024 the company signed a long-term hydrogen power purchase agreement with Wina Energy to secure renewable electricity for the Tampere site. Ren-Gas aims to accelerate emissions reduction in transport by scaling these plants across Finland. The recent €16 million growth round strengthens its balance sheet and funds initial construction and further project development.

Led · Equity · Sep 2025

Finnish Food Factory produces plant-based dairy products. Helsinki’s Taaleri Bioindustry has invested €10M in the company. The available excerpt does not specify the financing instrument, valuation, or use of proceeds. No operating metrics, revenue figures, or user counts are provided in the article. The report appeared on Silicon Canals, and the full article requires subscription access. No future plans or additional investors were disclosed in the excerpt.

Led · Series B · May 2024

Enifer spun out from the VTT Technical Research Centre of Finland in 2020 to commercialize Pekilo, a single-cell fungus mycoprotein originally developed by the paper industry in the 1960s–70s. Its core product is a dry powdered mycoprotein ingredient produced via fermentation on food-industry sidestreams (for example dairy waste like lactose) and processed to a neutral flavor for broad culinary use. The company intends to remain B2B, targeting uses from patties and cold cuts to yogurts, cheeses and pet food while also considering animal feed partnerships. Enifer is preparing novel-food applications, targeting EU clearance first and then Singapore and the U.S. The startup is building a fermenting and processing factory in Kirkkonummi that will produce 500 kg of protein per hour; it expects to start ramping operations in 2026 and says reaching full production capacity will take about three years. Its first factory has been fully funded through a mix of equity, loans and grants enabling the company to move toward commercial scale-up. Enifer develops PEKILO® mycoprotein ingredients produced through fungal fermentation; the product is a protein- and fiber-rich powder with neutral taste and color intended as a plant-protein substitute in foods. The company emphasizes recycling and reuse by converting industrial by-products and waste streams into feedstock for its fermentation process. Enifer plans to build a commercial-scale factory with roughly 3 million kilograms annual production capacity—equivalent to the protein from 30,000 cows—with at least 20× lower carbon emissions. The facility is projected to cost €30M, is being engineered with AFRY, will be located in the Uusimaa region with a site announcement expected in Q1 2024, and is expected to be completed by end of 2025 with production ramp-up in 2026. Enifer expects to file for regulatory approval of its food-grade ingredient in the first half of 2024. The company has ongoing partnerships with Skretting, Purina, and Valio, and previously raised an €11M Series A in spring 2023. eniferBio develops PEKILO, a fungus-derived mycoprotein produced through a specialized fermentation process that yields a protein-rich dried powder high in protein, healthy carbohydrates, fats and minerals. The product is positioned for multiple use cases including pet food and aquafeed and is already used in partnerships with companies such as Skretting, Purina and Valio. The company intends to use the new funding to scale up PEKILO production capacity. eniferBio is pursuing a next phase of developing consumer-fit products in collaboration with Valio. The company is led by CEO Simo Ellilä and is based in Espoo, Finland. Financially, the company completed a Series A raise to support its scaling plans.

Led · Equity · Mar 2022

Nordtreat is a Finnish technology company founded in 2015 that develops and produces bio-based, environmentally friendly flame retardants under its NORFLAM® brand. Its products comply with current fire protection regulations and have been used to protect more than 2,000 buildings and structures worldwide. The company relies on bio-based raw materials and targets demand for sustainable fire protection solutions, particularly in the wood-based construction industry. Nordtreat has expanded its product and service portfolio since founding and emphasizes certified fire retardants and flame retardant systems. As part of its growth plans it has agreed with Altana’s BYK division to jointly develop a bio-based flame retardant additive. Management states the new investors will help exploit the growth potential of the technology and accelerate market adoption of more environmentally friendly product solutions. Nordtreat develops and manufactures environmentally friendly, non-toxic fire retardants based on bio-based acids, with a patented fire protection technology focused especially on wood construction and building materials from renewable raw materials. The company’s products are commercialized to replace traditional fire retardants that contain compounds harmful to humans and the environment, such as boric acid, formaldehyde and ammonia. Founded in 2015, Nordtreat operates its own production plant in Vantaa and employs 22 people across Finland, France, Germany and Poland. The company has completed a latest financing round that raised a total of €4.0 million to support growth. Proceeds from the round will be used to accelerate international expansion, expand the product portfolio and develop production capacity at the Vantaa plant. Nordtreat positions itself for growth in the construction-products market as sustainability requirements tighten.

Led · Equity · Jun 2021

Tracegrow has developed a patented process that separates micronutrients from recycled alkaline batteries and industrial side streams to produce organic certified fertilizers. Its products are proven to reduce carbon emissions and enhance crop productivity compared to traditional methods. The company positions its technology as a circular-economy solution that reduces waste and addresses food-system challenges. Tracegrow has received a fresh capital boost from a Nordic foodtech investor and is set to expand operations. The new backing is intended to support the company's growth and scaling in the food system. The article reports that the investor and the CEO see significant potential for the technology to aid primary production’s transition toward more ecological and productive practices. Tracegrow is a Finnish cleantech company that converts metals recovered from used alkaline batteries into an organically certified liquid fertiliser (ZM-Grow™). Its fully automated, patent-protected process can reuse up to 90% of trace elements and has been in commercial-scale production since 2019. Tracegrow already sells its products in 15 countries and its fertiliser is approved for organic farming in the EU, UK and Australia. The company positions its products as low-carbon alternatives to conventional fertilisers with potential to significantly reduce CO2 emissions. Proceeds from the recent financing are earmarked to build a second production line in Kärsämäki to expand capacity and broaden the product portfolio. The investment will also support Tracegrow’s internationalisation plans and future plant investments.